A phase 2 study of ontuxizumab, a monoclonal antibody...

  • Main
  • 2017 / 11
  • A phase 2 study of ontuxizumab, a monoclonal antibody...
Investigational New Drugs 2017 / 11

A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma

D’Angelo, Sandra P., Hamid, Omid A., Tarhini, Ahmad, Schadendorf, Dirk, Chmielowski, Bartosz, Collichio, Frances A., Pavlick, Anna C., Lewis, Karl D., Weil, Susan C., Heyburn, John, Schweizer, Charles
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-017-0530-4
Date:
November, 2017
File:
PDF, 711 KB
english, 2017
Conversion to is in progress
Conversion to is failed